BLOOD-PRESSURE RESPONSE DURING LONG-TERM TREATMENT WITH MAGNESIUM IS DEPENDENT ON MAGNESIUM STATUS - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY IN ESSENTIAL-HYPERTENSION AND IN SUBJECTS WITH HIGH-NORMAL BLOOD-PRESSURE

被引：51
作者：
LIND, L [1 ]
LITHELL, H [1 ]
POLLARE, T [1 ]
LJUNGHALL, S [1 ]
机构：
[1] UNIV HOSP UPPSALA,DEPT INTERNAL MED,S-75185 UPPSALA,SWEDEN
来源：
AMERICAN JOURNAL OF HYPERTENSION | 1991年 / 4卷 / 08期
关键词：
MAGNESIUM; BLOOD PRESSURE; HYPERTENSION;
D O I：
10.1093/ajh/4.8.674
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
Both experimental and epidemiological studies support the idea of magnesium supplementation in essential hypertension. We added 15 mmol Mg to a free diet in 71 subjects with mild essential hypertension or a high-normal blood pressure in a double-blind, placebo-controlled study over 6 months. The treatment, which raised urinary magnesium excretion 30%, induced no general effects on the blood pressure. However, when the changes in blood pressure in the actively treated group were related to the pretreatment magnesium status, a correlation was found between pretreatment urinary magnesium excretion and the induced change in supine blood pressure (P < .05) with a blood pressure reduction in subjects with a low pretreatment urinary excretion of magnesium, and a pressor effect in the subjects with the highest pretreatment levels of urinary magnesium. The induced change in blood pressure was furthermore found to be inversely correlated to the changes in serum magnesium and urinary excretion of sodium (P < .03) induced by treatment indicating that both a direct calcium antagonist action of magnesium at the cellular level as well as a diuretic effect of the increased magnesium load might be involved in the blood pressure effects of magnesium. Pretreatment serum potassium concentration also appeared to be a predictor of the induced change in standing blood pressure (P < .03). In conclusion, magnesium supplementation does not seem to be effective in unselected mild hypertensive subjects or in subjects with a high-normal blood pressure and can therefore not be generally recommended. However, in subjects with a low urinary excretion of magnesium, probably representing magnesium deficiency and/or a low magnesium intake, a hypotensive effect, was seen. This finding deserves further investigation.
引用
收藏
页码：674 / 679
页数：6
相关论文
共 27 条
  • [1] Erne P., Bolli P., Burgiesser E., Buhler F.R., Correlation of platelet calcium with blood pressure-effect of antihypertensive therapy, N Engl J Med, 310, pp. 1084-1088, (1980)
  • [2] Hvarfner A., Larsson R., Morlin C., Et al., Cytosolic free calcium in platelets-relationship to blood pressure and indices of systemic calcium metabolism, J Hypertens, 6, pp. 71-77, (1988)
  • [3] Ueno H., Mikawa M., Takata M., Et al., Does Cytosolic Free Calcium Concentration in Platelets Reflect Tone and Structured Changes of Resistance Vessels (Abst). Xllth Scientific Meeting of the Society of Hypertension, Abstract, 448, (1988)
  • [4] Altura B.M., Altura B.T., Role of magnesium ions in contractility of blood vessels and skeletal muscles, Magnesium Bull, 1, pp. 102-114, (1981)
  • [5] Ji B.H., Erne W., Kiowski W., Et al., Magnesium-induced vasodilation is comparable to that induced by calcium entry blockade, J Hypertens 1983
  • [6] L(Suppl, 2, pp. 368-371
  • [7] Petersen B., Schroll M., Christiansen C., Transbol I., Serum and erythrocyte magnesium in normal elderly Danish people, Acta Med Scand, 201, pp. 31-34, (1977)
  • [8] Lind L., Wengle B., Wide L., Et al., Hypertension in primary hyperparathyroidism-reduction of blood pressure by long-term treatment with vitamin D (Alphacalcidol). A double-blind, placebo-controlled study, Am J Hypertens, 1, pp. 397-402, (1988)
  • [9] Lind L., Wengle B., Ljunghall S., Blood pressure is lowered by vitamin D (Alphacalcidol) during long-term treatment of patients with intermittent hypercalcemia. A doubleblind, placebo-controlled study, Acta Med Scand, 222, pp. 423-427, (1987)
  • [10] Albert D.G., Morita Y., Iseri L.T., Serum magnesium and plasma sodium levels in essential vascular hypertension, Circulation, 17, pp. 761-764, (1958)
123